On Nov 1, 2021 InterveXion Therapeutics closed a Grant round and raised $13,800,000 from National Institutes of Health, featuring lead investors National Institutes of Health.
About the company: InterveXion Therapeutics is located at United States, North America.
“”
Company website: http://www.intervexion.com